2.50
Hdl Handle:
http://hdl.handle.net/10541/81240
Title:
Management of the menopause in cancer survivors.
Authors:
Clemons, Mark; Clamp, Andrew R; Anderson, Beverley
Abstract:
The consequences of premature menopause are of great importance to cancer survivors. Oestrogen replacement therapy (with and without added progestins) is the most extensively researched agent for the treatment and prevention of menopausal problems. While this may be appropriate for symptom control in patients with tumours that are not hormone responsive, patients with hormone dependent tumours will require safe and effective alternative treatments for menopausal symptoms. This paper will discuss both the short-term and long-term consequences of the menopause in cancer survivors and will also offer various management strategies.
Affiliation:
Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, Ont., Canada. mark.clemons@tsrcc.on.ca
Citation:
Management of the menopause in cancer survivors. 2002, 28 (6):321-33 Cancer Treat. Rev.
Journal:
Cancer Treatment Reviews
Issue Date:
Dec-2002
URI:
http://hdl.handle.net/10541/81240
PubMed ID:
12470982
Type:
Article
Language:
en
ISSN:
0305-7372
Appears in Collections:
All Christie Publications ; All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorClemons, Mark-
dc.contributor.authorClamp, Andrew R-
dc.contributor.authorAnderson, Beverley-
dc.date.accessioned2009-09-16T10:24:07Z-
dc.date.available2009-09-16T10:24:07Z-
dc.date.issued2002-12-
dc.identifier.citationManagement of the menopause in cancer survivors. 2002, 28 (6):321-33 Cancer Treat. Rev.en
dc.identifier.issn0305-7372-
dc.identifier.pmid12470982-
dc.identifier.urihttp://hdl.handle.net/10541/81240-
dc.description.abstractThe consequences of premature menopause are of great importance to cancer survivors. Oestrogen replacement therapy (with and without added progestins) is the most extensively researched agent for the treatment and prevention of menopausal problems. While this may be appropriate for symptom control in patients with tumours that are not hormone responsive, patients with hormone dependent tumours will require safe and effective alternative treatments for menopausal symptoms. This paper will discuss both the short-term and long-term consequences of the menopause in cancer survivors and will also offer various management strategies.en
dc.language.isoenen
dc.subjectCanceren
dc.subjectOestrogen Replacement Therapyen
dc.subject.meshAdult-
dc.subject.meshCardiovascular Diseases-
dc.subject.meshClimacteric-
dc.subject.meshEstrogen Replacement Therapy-
dc.subject.meshFemale-
dc.subject.meshHot Flashes-
dc.subject.meshHumans-
dc.subject.meshMenopause, Premature-
dc.subject.meshMiddle Aged-
dc.subject.meshNeoplasms-
dc.subject.meshOsteoporosis-
dc.titleManagement of the menopause in cancer survivors.en
dc.typeArticleen
dc.contributor.departmentDivision of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, Ont., Canada. mark.clemons@tsrcc.on.caen
dc.identifier.journalCancer Treatment Reviewsen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.